Ophthalmology · Houston, TX
NPI
1659569648
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
845 Fm 1960 Rd W
Houston, TX, 77090
Phone (281) 893-1760
Groups this clinician bills Medicare through
Medicare paid, 2024
$279K
3,396 services
Medicare patients, 2024
1,023
Average age 76
Drug cost, 2024
$1.1M
3,098 prescriptions
Company payments, 2025
$1,515
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Judy Y Chang Strepka was code 92014 (ophthalmological e&m), 813 times for 794 patients. In total Judy Y Chang Strepka billed 3,396 services in 29 codes, and Medicare paid $279K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 813 | 794 | $85.76 | $70K |
| 92012 Ophthalmological E&M | Office | 596 | 357 | $59.54 | $35K |
| 92133 Computerized Ophthalmic Imaging | Office | 332 | 323 | $25.87 | $8,588 |
| 92134 Computerized Ophthalmic Imaging | Office | 291 | 277 | $29.53 | $8,592 |
| 92083 Vision, Hearing, and Speech Services | Office | 243 | 228 | $43.55 | $11K |
| 92136 Ultrasound - Nonspecific | Office | 197 | 112 | $30.51 | $6,011 |
| 66984 Cataract Surgery | Facility | 191 | 106 | $422.39 | $81K |
| 92004 Ophthalmological E&M | Office | 123 | 123 | $97.13 | $12K |
| 66821 Cataract Surgery | Office | 120 | 98 | $242.18 | $29K |
| 76514 Ultrasound - Nonspecific | Office | 86 | 83 | $7.39 | $636 |
| 92020 Ophthalmological E&M | Office | 25 | 25 | $18.31 | $458 |
| 68761 Eye | Office | 14 | 12 | $120.36 | $1,685 |
| 99203 Office E&M - New | Office | 12 | 12 | $76.41 | $917 |
By year: 2022 $277K for 3,463 services; 2023 $312K for 3,770 services; 2024 $279K for 3,396 services.
Medicare prescription drug claims, 2024
In 2024, the drug Judy Y Chang Strepka prescribed most often to Medicare patients was Latanoprost, with 522 prescriptions and refills. In total Judy Y Chang Strepka wrote 3,098 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 522 | 1,133 | 148 | $5,505 |
| Lumigan Bimatoprost | 327 | 595 | 81 | $155K |
| Restasis Cyclosporine | 249 | 453 | 132 | $271K |
| Lotemax Sm Loteprednol Etabonate | 187 | 189 | 105 | $46K |
| Besivance Besifloxacin Hcl | 182 | 185 | 114 | $40K |
| Prolensa Bromfenac Sodium | 169 | 180 | 110 | $58K |
| Moxifloxacin Moxifloxacin Hcl | 158 | 158 | 101 | $3,202 |
| Timolol Maleate Generic | 114 | 279 | 41 | $1,450 |
| Cyclosporine Generic | 105 | 248 | 62 | $74K |
| Xiidra Lifitegrast | 105 | 185 | 41 | $119K |
| Brimonidine Tartrate Generic | 105 | 246 | 42 | $7,571 |
| Miebo Perfluorohexyloctane/Pf | 102 | 130 | 32 | $89K |
| Alphagan P Brimonidine Tartrate | 76 | 124 | 20 | $25K |
| Prednisolone Acetate Generic | 72 | 80 | 47 | $2,382 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 69 | 131 | 21 | $11K |
Brand drugs: 2,144 claims; generic drugs: 954 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Judy Y Chang Strepka $1,515 ($1,515 in general payments such as food, travel and fees) from 17 companies. The largest payer was Bausch & Lomb Americas Inc. with $249.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 14 | $249 |
| Harrow Eye, LLC | 8 | $236 |
| Abbvie Inc. ABBV | 10 | $193 |
| Tarsus Pharmaceuticals, Inc. TARS | 7 | $162 |
| Alcon Vision LLC ALC | 10 | $151 |
| Dompe US, Inc. | 3 | $98.33 |
| Astellas Pharma US Inc 4503.T | 4 | $88.88 |
| Ocular Therapeutix, Inc. OCUL | 3 | $69.85 |
| Sight Sciences, Inc. SGHT | 2 | $54.41 |
| Amgen Inc. AMGN | 2 | $39.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.